By analyzing the LRRC15 expression profile of a series of 425 STS with available clinical data (Table S1), we found that high LRRC15 expression was significantly associated with worse metastases-free survival in multivariate analysis (Figure 2 and Table 2). This evidence concerns the gene LRRC15 and telomere syndrome.